Free shipping

Orlynvah for bladder infection: four label and trial checks

A restricted U.S. indication and a combined symptom-and-culture endpoint need careful reading.

A woman with silver-streaked dark curls discusses a printed urine-culture report with a pharmacist.
In this article
  1. Check the restricted indication
  2. Check who counted in the trial
  3. Check which susceptibility group a claim describes
  4. Check allergies and interacting medicines

Before filling an Orlynvah prescription, ask the prescriber to explain the organism, the available alternatives and the follow-up plan. The reason for choosing this medicine should be specific enough to write beside your urine-culture result.

Check the restricted indication

Orlynvah combines sulopenem etzadroxil and probenecid. Its U.S. indication covers adult women with uncomplicated UTIs from E. coli, K. pneumoniae or P. mirabilis and limited or no alternative oral antibiotics. Complicated UTIs, including oral treatment after intravenous therapy, are excluded.1

Check who counted in the trial

REASSURE randomized 2,222 women; its culture-confirmed efficacy analysis included 990. Overall success required both clinical cure and microbiologic eradication at day 12. Success occurred in 318/522 (60.9%) with sulopenem/probenecid and 260/468 (55.6%) with amoxicillin/clavulanate.2

The 5.4-percentage-point difference (95% confidence interval −0.8 to 11.5) ruled out the trial’s predefined 10-percentage-point loss in success, without proving overall superiority. Diarrhea occurred in 8.1% versus 4.1%, respectively.23

Check which susceptibility group a claim describes

Among participants whose bacteria were susceptible to amoxicillin/clavulanate, combined success favored Orlynvah: 61.7% versus 55.0%. Clinical cure alone was 77.3% versus 76.7%. The combined result did not establish a comparable symptom benefit.12

Only 67 participants had bacteria nonsusceptible to amoxicillin/clavulanate, too few to establish efficacy.1

Check allergies and interacting medicines

The December 2025 label contraindicates ketorolac, known uric acid kidney stones, and hypersensitivity to its ingredients or other beta-lactam antibiotics. Bring medicine names and previous reaction details.1

Write down the plan if symptoms change

Ask: “Why are the other oral options unsuitable, and who reviews my culture result if it arrives after I start treatment?” Keep the answer and the contact details with the prescription.

Fever and chills, back, side or groin pain, and nausea or vomiting can indicate kidney infection. NIDDK advises seeking care right away for kidney-infection symptoms.4

Our fosfomycin and nitrofurantoin comparison discusses different antibiotic trials. Laugh, Sneeze, Jump explains how to record burning, infection start dates and changing urgency together. Those dated notes can help when infections and ongoing bladder symptoms need discussion.

For education, not antibiotic selection or dosing advice. Do not change a prescription or take leftover antibiotics without clinical review.

Read our health disclaimer

Girl Playbook sells this book. It provides education and worksheets, not individualized medical care.

Sources

The research behind this article, in the order it’s cited. How we source our articles.

  1. DailyMed, National Library of MedicineOrlynvah: prescribing information, revised December 2025 (opens in a new tab)abcd
  2. NEJM Evidence, 2025Sulopenem versus Amoxicillin/Clavulanate for the Treatment of Uncomplicated Urinary Tract Infection (opens in a new tab)abc
  3. ClinicalTrials.gov, sponsor-provided documentREASSURE analysis plan (opens in a new tab)↩
  4. National Institute of Diabetes and Digestive and Kidney DiseasesSymptoms & Causes of Kidney Infection (Pyelonephritis) (opens in a new tab)↩

Spotted something out of date? Tell us and we’ll check it.

Private questions deserve good answers.

Ten Playbooks, one for each of the problems women rarely talk about.

Shop the Playbooks